In a study by Chen et al., a popular drug used for the treatment of diabetes, metformin, was shown to decrease prostate cancer cell proliferation, migration and tumor growth through a mechanism that involved the upregulation of PEDF [58]. Here, SERPINF1 is linked to neoplasm.